of 83
8/8/2019 Vavouranakis ECG Monitoring
1/83
,
, ,
8/8/2019 Vavouranakis ECG Monitoring
2/83
,
:
, , , (Holter) 24
, ,
8/8/2019 Vavouranakis ECG Monitoring
3/83
) -
8/8/2019 Vavouranakis ECG Monitoring
4/83
.
8/8/2019 Vavouranakis ECG Monitoring
5/83
P
R
Q
S
0,200,20 secsec
0,50,5
mVmV
T
P < 0.12
PR 0.12 0.20
QRS < 0.12
QT < 0.45
8/8/2019 Vavouranakis ECG Monitoring
6/83
P
QRS
II aVR
8/8/2019 Vavouranakis ECG Monitoring
7/83
8/8/2019 Vavouranakis ECG Monitoring
8/83
3
+ -
R L
F
3
6 I II III aVR aVLaVF V1 V2 V3 V4 V5 V6
+ -
R L
F
+ -
R L
F
+ -
R L
F
+ -
R L
F
+ -
R L
F
+ -
R L
F
12
8/8/2019 Vavouranakis ECG Monitoring
9/83
8/8/2019 Vavouranakis ECG Monitoring
10/83
8/8/2019 Vavouranakis ECG Monitoring
11/83
B. : ST .
C. : ST
.
D. : 10-12 q . ST
.E-F. : q qs 3-6 . ST >3 .
8/8/2019 Vavouranakis ECG Monitoring
12/83
8/8/2019 Vavouranakis ECG Monitoring
13/83
V1-V4. rS V1 Q V2-V4
8/8/2019 Vavouranakis ECG Monitoring
14/83
ST V1-V3 V4.
QS V1-V4
8/8/2019 Vavouranakis ECG Monitoring
15/83
8/8/2019 Vavouranakis ECG Monitoring
16/83
ST V5-V6 I, aVL
8/8/2019 Vavouranakis ECG Monitoring
17/83
ST II,III, aVF
I, aVL,
8/8/2019 Vavouranakis ECG Monitoring
18/83
. ST -
ST.
ST
.
ST
.
!!! ST .
8/8/2019 Vavouranakis ECG Monitoring
19/83
.
1. .
2.
3.
4.
1.
2. 1 2
3. 3
4. His
1.
2.
8/8/2019 Vavouranakis ECG Monitoring
20/83
1.
2. 3.
8/8/2019 Vavouranakis ECG Monitoring
21/83
4 .
16%
4%
6%
34%
7%
8/8/2019 Vavouranakis ECG Monitoring
22/83
8/8/2019 Vavouranakis ECG Monitoring
23/83
1.
80 % .
.
8/8/2019 Vavouranakis ECG Monitoring
24/83
QRS : (>0.12sec) P
1.
8/8/2019 Vavouranakis ECG Monitoring
25/83
2.
60-100 /
20% 2
: Purkinje
.
8/8/2019 Vavouranakis ECG Monitoring
26/83
3.)
QRS>120ms, 100 /
>30 sec.
8/8/2019 Vavouranakis ECG Monitoring
27/83
3.)
3
> 100/
8/8/2019 Vavouranakis ECG Monitoring
28/83
8/8/2019 Vavouranakis ECG Monitoring
29/83
12 12
.
.
QRS .
QRS
8/8/2019 Vavouranakis ECG Monitoring
30/83
4.
.
!
8/8/2019 Vavouranakis ECG Monitoring
31/83
8/8/2019 Vavouranakis ECG Monitoring
32/83
1.
8/8/2019 Vavouranakis ECG Monitoring
33/83
2.1
PQ> 0,20 sec
P QRS
2. 2
8/8/2019 Vavouranakis ECG Monitoring
34/83
2. 2
. Mobitz I (Wenckebach)
.
PR . RR.
(pattern) .. 4 : 3 , 6 : 5.
8/8/2019 Vavouranakis ECG Monitoring
35/83
. Mobitz I
2
.
PR . .
) 1 P ( )) 2 P ( )
8/8/2019 Vavouranakis ECG Monitoring
36/83
8/8/2019 Vavouranakis ECG Monitoring
37/83
( .. , ,
) ( .. , Reiter,
)
Lyme
.
8/8/2019 Vavouranakis ECG Monitoring
38/83
8/8/2019 Vavouranakis ECG Monitoring
39/83
5.
QRS >120msec
R
(V6, I, aVL)-
Qs r S
(V1)
8/8/2019 Vavouranakis ECG Monitoring
40/83
8/8/2019 Vavouranakis ECG Monitoring
41/83
4.
QRS >120msec
R (rSR)(V1-V2)
- S (V6, I ,aVL)
V1, V2
12
3
1
2
3
8/8/2019 Vavouranakis ECG Monitoring
42/83
4.
1
2
3
8/8/2019 Vavouranakis ECG Monitoring
43/83
6.
(-45 -90)rS II, III, aVFqR I, aVLQRS
8/8/2019 Vavouranakis ECG Monitoring
44/83
7.
(>120)rS I, aVLqR QRS
8/8/2019 Vavouranakis ECG Monitoring
45/83
8.
RBBB+LAH
RBBB+LP
8/8/2019 Vavouranakis ECG Monitoring
46/83
9.
RBBBLAH (LPH)
PQ >0,20 sec
8/8/2019 Vavouranakis ECG Monitoring
47/83
5.
.
.
10 % .
.
8/8/2019 Vavouranakis ECG Monitoring
48/83
8/8/2019 Vavouranakis ECG Monitoring
49/83
! !
8/8/2019 Vavouranakis ECG Monitoring
50/83
.
.
:
,
,
.
8/8/2019 Vavouranakis ECG Monitoring
51/83
. 12
II. (SAECG)
I. (T wave alternans)
( wave variability).
IV.
(Heart rate variability)
V. Holter 24.
.
8/8/2019 Vavouranakis ECG Monitoring
52/83
. 12
- 24h
- QRS- - QT- QT
8/8/2019 Vavouranakis ECG Monitoring
53/83
8/8/2019 Vavouranakis ECG Monitoring
54/83
QRS >120msec
(His Purkinje) .
-
8/8/2019 Vavouranakis ECG Monitoring
55/83
1638 patients with documented coronaryartery disease, nonsustained ventriculartachycardia, depressed (ejection fraction40%) left ventricular function
Were randomized to electrophysiology-
guided antiarrhythmic therapy or tono specific antiarrhythmic therapy(standard medical therapy,including-adrenergic blocking agents andACE inhibitors .
8/8/2019 Vavouranakis ECG Monitoring
56/83
8/8/2019 Vavouranakis ECG Monitoring
57/83
MUSTT
LBBB
49%
44%
QRS120msec
8/8/2019 Vavouranakis ECG Monitoring
58/83
Incidence, predictors, and outcomes of high-degreeatrioventricular block complicating acute myocardialinfarction treated with thrombolytic therapy
Atrioventricular block (AVB) is a commoncomplication of acute myocardial infarction(MI).
In the prethrombolytic era, second or thirddegree heart block was seen in
approximately 5% to 7% of patientspresenting with acute
In the setting of inferior MI, the incidenceof second or third degree heart block can
be as high as 28%.
8/8/2019 Vavouranakis ECG Monitoring
59/83
Thrombolytic therapy has
substantially decreased the mortalityassociated with acute MI,
the incidence of AVB, particularly inthe setting of inferior MI, remains
high AVB also occurs, though less
commonly, in acute anterior MI.
Incidence, predictors, and outcomes of high-degreeatrioventricular block complicating acute myocardialinfarction treated with thrombolytic therapy
n
c ence, pre c ors, an ou comes o g - egree
8/8/2019 Vavouranakis ECG Monitoring
60/83
In the GUSTO-I trial, AVB occurred inabout 4% of patients with anterior MIs, arate similar to that seen in previous
studies. The development of AVB, particularly in
anterior MI, has been shown to conferhigher in-hospital and long-term mortality.
Atrioventricular block in the setting ofinferior MI is also associated with higherin-hospital mortality; its effect on long-termmortality is uncertain
, p , g gatrioventricular block complicating acute myocardialinfarction treated with thrombolytic therapy
8/8/2019 Vavouranakis ECG Monitoring
61/83
QT
:370-460msec 400-470msec
QTc=QT/RR Bazett.
QT
: QTc > 440msec .
8/8/2019 Vavouranakis ECG Monitoring
62/83
QT
8/8/2019 Vavouranakis ECG Monitoring
63/83
8/8/2019 Vavouranakis ECG Monitoring
64/83
8/8/2019 Vavouranakis ECG Monitoring
65/83
QT
.
QT (max-min) 12 .
70msec .
8/8/2019 Vavouranakis ECG Monitoring
66/83
8/8/2019 Vavouranakis ECG Monitoring
67/83
8/8/2019 Vavouranakis ECG Monitoring
68/83
QTd>120msec .
8/8/2019 Vavouranakis ECG Monitoring
69/83
40msec
QRS.
, ,
.
: .
II.
(Signal Average ECG)
8/8/2019 Vavouranakis ECG Monitoring
70/83
QRS 114msec,
LAS>38msec,
RMS
8/8/2019 Vavouranakis ECG Monitoring
71/83
. : .
.
: : , .
III. (T wave alternans)
( wave variability)
8/8/2019 Vavouranakis ECG Monitoring
72/83
III. (T wave alternans)
( wave variability)
III (T lt )
8/8/2019 Vavouranakis ECG Monitoring
73/83
III. (T wave alternans)
( wave variability)
MADIT II
.
8/8/2019 Vavouranakis ECG Monitoring
74/83
8/8/2019 Vavouranakis ECG Monitoring
75/83
1987 : Kleiger 808
31 ...
34%
12%
IV.
(Heart rate variability)
8/8/2019 Vavouranakis ECG Monitoring
76/83
R Kleiger et al Am J Cardiol
8/8/2019 Vavouranakis ECG Monitoring
77/83
R Kleiger et al Am J Cardiol
IV
8/8/2019 Vavouranakis ECG Monitoring
78/83
.
CABG, .
10 min 24 h Holter 24.
IV.
(Heart rate variability)
8/8/2019 Vavouranakis ECG Monitoring
79/83
(PVC )
8/8/2019 Vavouranakis ECG Monitoring
80/83
(PVCs)
VPCs >10/h .
(NSVT)
.
NSVT , , : .
QT (QT dynamics)
QT : QT/RR QT .
8/8/2019 Vavouranakis ECG Monitoring
81/83
12 -
, .
10
.
8/8/2019 Vavouranakis ECG Monitoring
82/83
8/8/2019 Vavouranakis ECG Monitoring
83/83